Today: 25 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

NVIDIA Corporation pushes deeper into factory AI with ABB robot deal ahead of GTC

NVIDIA Corporation pushes deeper into factory AI with ABB robot deal ahead of GTC

ABB’s robotics unit will integrate NVIDIA’s Omniverse libraries into its RobotStudio software, aiming for up to 99% accuracy between virtual training and real-world robot deployment. Foxconn is piloting the system in electronics assembly. The product, RobotStudio HyperReality, is set for release in the second half of 2026. The deal comes as Nvidia faces investor pressure for new growth beyond data-center chips.
9 March 2026
····
Lumentum Holdings Stock Jumps as S&P 500 Addition Extends Nvidia-Linked AI Optics Rally (News Release Archive)

Lumentum Holdings Stock Jumps as S&P 500 Addition Extends Nvidia-Linked AI Optics Rally (News Release Archive)

Lumentum shares rose 10.6% to $617.81 in New York trading after S&P Dow Jones Indices said it will add the company to the S&P 500 on March 23. The move follows Nvidia’s $2 billion investment and a multiyear purchase agreement announced last week. Peers Coherent and Vertiv also gained. Lumentum reported second-quarter revenue up 65.5% to $665.5 million and forecast third-quarter revenue of up to $830 million.
9 March 2026
···········
Stock Market Today: Wall Street Slides as Oil Nears $120 and Weak Jobs Data Stoke Stagflation Fears

Stock Market Today: Wall Street Slides as Oil Nears $120 and Weak Jobs Data Stoke Stagflation Fears

Wall Street dropped about 1.3% Monday as oil neared $120 a barrel after Iran named Mojtaba Khamenei supreme leader and President Trump ruled out talks. U.S. employers cut 92,000 jobs in February, pushing unemployment to 4.4%. Airlines and cruise stocks led losses, while energy gained. Brent crude hit $119.50 before easing as G7 and Saudi Arabia discussed responses but held off on releasing reserves.
9 March 2026
···
Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens

Jefferies Financial Group Inc Says MFS Losses Seen Under $20 Million as Western Alliance Clash Deepens

Jefferies Financial Group said losses from the collapse of UK lender Market Financial Solutions would likely stay under $20 million and denied owing Western Alliance $126.4 million over First Brands loans. Jefferies shares fell about 3% Monday after Morgan Stanley downgraded the stock, citing credit and legal risks. Western Alliance sued Friday, alleging Jefferies breached a loan agreement. Jefferies said the loan was non-recourse.
9 March 2026
··
Red Cat Holdings Stock Swings After Pentagon Drone Results Cool Rally Ahead of March 18 Earnings

Red Cat Holdings Stock Swings After Pentagon Drone Results Cool Rally Ahead of March 18 Earnings

Red Cat Holdings shares fell about 4% Monday after its Teal Drones unit was listed among 11 finalists for Pentagon drone contracts, cooling a rally that sent the stock to a one-year high last week. The company expects to report fourth-quarter revenue of $24–$26.5 million on March 18, up sharply from a year earlier, but warned those figures are unaudited.
9 March 2026
····
Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics Stock Jumps 18% as FDA Shake-Up Puts Ebvallo Back in Focus

Atara Biotherapeutics shares jumped 18% Monday after reports that FDA biologics chief Vinay Prasad will depart in April. The move follows the agency’s January rejection of Atara’s EBVALLO therapy for a rare blood cancer, which wiped out 56% of the stock’s value. Atara and partner Pierre Fabre have requested a Type A meeting with the FDA to revisit the decision. Atara ended 2025 with $8.5 million in cash.
9 March 2026
····
Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds

Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds

Capricor Therapeutics shares jumped 7.6% to $30.01 after the company set March 12 for its quarterly and annual update, spotlighting its Duchenne muscular dystrophy therapy, deramiocel. An MDA conference abstract showed deramiocel met main goals in a 106-patient Phase 3 trial, with no imbalance in severe adverse events. The FDA rejected approval in July but later requested the full study report.
9 March 2026
·
Nasdaq Partners With Kraken on Tokenized Stocks, Eyes 2027 Launch

Nasdaq Partners With Kraken on Tokenized Stocks, Eyes 2027 Launch

Nasdaq announced plans for a tokenized shares framework and will partner with Payward, parent of crypto exchange Kraken, to build a gateway linking regulated stock markets to blockchain networks. The program is set to launch in the first half of 2027. Kraken will help distribute tokenized shares in Europe and other markets outside the U.S. The plan requires SEC approval and updated market infrastructure.
9 March 2026
·····
Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals shares traded at $21.24 Monday, just below Servier’s $21.50-per-share cash offer in a $2.5 billion takeover. The deal would give Servier Ojemda, the only U.S.-approved single-drug treatment for pediatric low-grade glioma, with 2025 sales of $155.4 million. The tender offer has not started and closing depends on shareholder response and U.S. antitrust clearance.
9 March 2026
W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore reported a preliminary 2025 net loss of $150.1 million, up from $87.1 million in 2024, as revenue dropped to $501.5 million and free cash flow plunged to $1.5 million. Average oil selling price fell to $64.09 a barrel, though production slightly increased. Year-end liquidity rose to $184.5 million, and net debt declined. The company warned results are unaudited and may change before its March 16 filing.
9 March 2026
·
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals enacted a 1-for-20 reverse stock split early Monday to boost its share price and avoid a Nasdaq delisting. The company faces a March 27 deadline to meet the $1 minimum bid rule. Reviva is also seeking funding for a new Phase 3 trial of its schizophrenia drug after the FDA requested more data. Analyst Jason Kolbert downgraded the stock, citing unchanged fundamentals.
9 March 2026
·
uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure shares surged 34% to $14.27 in U.S. premarket trading Monday after news that FDA biologics chief Vinay Prasad will step down in April. The move follows a dispute over the agency’s demand for a new sham-surgery trial of uniQure’s Huntington’s gene therapy. The FDA has not agreed to approve the treatment based on current data. uniQure ended 2025 with $622.5 million in cash and investments.
9 March 2026
·
Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Brent crude topped $100 a barrel for the first time since 2022 as the U.S.-Israeli war with Iran disrupted the Strait of Hormuz and Gulf states cut oil output. S&P 500 futures fell 1.2% after a weak U.S. jobs report, while the VIX volatility index hit its highest since April 2025. Hundreds of tankers remained idle, and G7 finance ministers discussed a possible coordinated release of emergency oil reserves.
9 March 2026
·
3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems reported fourth-quarter revenue of $106.3 million, up 16% from the prior quarter and above its forecast, but still down 4% from a year earlier. Full-year revenue dropped 12% to $386.9 million, with a net income gain driven by asset sales and cost cuts. Healthcare Solutions rose 25% while Industrial Solutions fell 21%. The company expects a first-quarter revenue decline and continued losses.
9 March 2026
··
Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings will acquire drone maker Powerus in an all-stock deal to take it public, renaming the combined company Powerus Corp and targeting a summer 2026 Nasdaq listing as PUSA. South Korea's KCGI committed to buy $50 million in Powerus stock, while Aureus arranged $9 million in new financing. The deal still requires SEC and shareholder approval. AGH shares rose 12.8% in premarket trading.
9 March 2026
·
1 … 59 60 61 62 63 … 751

Stock Market Today

  • Maharashtra Scooters Shows Strong 17% EPS Growth, Signaling Investment Potential
    April 24, 2026, 11:13 PM EDT. Maharashtra Scooters (NSE:MAHSCOOTER) reported a significant 17% annual growth in earnings per share (EPS) over the past three years, highlighting its profitability amidst a market favoring stable companies over speculative losses. The firm posted improved earnings before interest and tax (EBIT) margins rising to 99%, alongside revenue growth, signaling robust operational performance. Insider holdings valued at ₹4.5 billion underscore strong alignment of interests with shareholders, providing added confidence in corporate strategy. Investors are cautioned to assess the company's balance sheet strength, despite these positive indicators. This blend of steady EPS growth and insider conviction makes Maharashtra Scooters an intriguing option for those prioritizing earnings growth in their investment decisions.

Latest article

LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

25 April 2026
LightPath Technologies shares closed up 10.05% at $16.09 in Orlando Friday, after hitting $16.53 and surpassing recent analyst targets. Trading volume jumped to 6.35 million shares. The company reported a $97.8 million backlog and second-quarter revenue of $16.4 million, up 120% from a year earlier. Recent orders and investor focus center on defense optics and infrared camera systems.
Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

25 April 2026
Wolfspeed shares surged 13.36% to $31.23 on Friday, with trading volume hitting 8.4 million shares ahead of its May 5 earnings report. The chipmaker recently cut its debt by about $97 million and lowered annual interest expense by $62 million after refinancing in March. Wolfspeed reported a $151 million net loss last quarter and expects negative gross margins to continue.
VeriSign Falls After Q1 Beat as .Com Price Hike Puts Renewal Risk in Focus

VeriSign Falls After Q1 Beat as .Com Price Hike Puts Renewal Risk in Focus

25 April 2026
VeriSign reported first-quarter revenue of $429 million, up 6.6%, and net income of $215 million, as .com and .net registrations rose to 176.1 million. Shares fell 2.8% Friday to $269.20 after the company announced a Nov. 1 increase in the wholesale .com fee to $10.97. Management raised its 2026 growth outlook for domain registrations. Investors remain cautious over renewal and pricing risks.
Go toTop